SANDRA CYRIL: Open Payments
NPI 1184653271 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 65 payments from 19 companies in 2025. Trend: 2023 $2,247 · 2024 $2,977 · 2025 $2,160
Food & beverage: $2,065Education: $95
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $730 |
| LEO Pharma Inc. | 4 | $154 |
| GENZYME CORPORATION | 5 | $149 |
| ABBVIE INC. | 9 | $146 |
| PFIZER INC. | 3 | $139 |
| Organon LLC | 7 | $131 |
| Janssen Biotech, Inc. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| UCB, Inc. | 3 | $82 |
Products named: NEMLUVIO, DUPIXENT, ANZUPGO, VTAMA, TREMFYA, SKYRIZI, LITFULO, Bimzelx.
Industry payments across FL — which companies pay providers there.
